Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitus
Propolis is a common remedy in Chinese medicine. We have previously demonstrated the anti-diabetic potentials of Nigerian propolis. However, the underlying mechanisms against type-2 diabetes mellitus (T2DM) remain unclear. This study used network pharmacology-based analysis to unravel the possible m...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-12-01
|
| Series: | Pharmacological Research - Modern Chinese Medicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667142522001439 |
| _version_ | 1811178175876562944 |
|---|---|
| author | Emmanuel I. Ugwor Adewale S. James Adekunle I. Amuzat Emmanuel O. Ezenandu Victory C. Ugbaja Regina N. Ugbaja |
| author_facet | Emmanuel I. Ugwor Adewale S. James Adekunle I. Amuzat Emmanuel O. Ezenandu Victory C. Ugbaja Regina N. Ugbaja |
| author_sort | Emmanuel I. Ugwor |
| collection | DOAJ |
| description | Propolis is a common remedy in Chinese medicine. We have previously demonstrated the anti-diabetic potentials of Nigerian propolis. However, the underlying mechanisms against type-2 diabetes mellitus (T2DM) remain unclear. This study used network pharmacology-based analysis to unravel the possible mechanisms of NP's anti-T2DM activity. Previously identified compounds in NP were retrieved from literature, screened for drug-likeness, and used to retrieve targets associated with T2DM, from which compound-target, protein-protein interaction, and target-pathways networks were constructed. Network pharmacology-based and enrichment analyses were conducted on the networks. Further, NP's inhibitory activity against targets identified in network analyses was assessed in-vitro. Library search revealed 202 previously reported compounds in NP; 96 were retained after screening for drug-likeness. However, only 44 NP compounds interacted with T2DM-associated targets, with 2-ethyl-1,4-dimethoxybenzene as the most active component. Network analyses revealed 167 putative targets, with HSP90AA1, JUN, ESR1, STAT3, CYP3A4, PTGS2, RELA, VEGFA, CYP2C9, and PPARG as the core anti-T2DM targets of NP compounds. Gene ontology analyses indicated that these targets were predominantly localised in the plasma membrane and cytoplasm and primarily involved in regulatory, signal transduction and cellular response processes. KEGG pathway enrichment implicated metabolic pathways (involving lipids), AGE-RAGE, and calcium/cAMP, among others, in the anti-T2DM effects of the compounds. Furthermore, in vitro pharmacological assessment demonstrated appreciable inhibitory effects of 2-ethyl-1,4-dimethoxybenzene against α-amylase, α-glucosidase, and HMG-CoA reductase. This study provides holistic mechanistic insights into the anti-T2DM activities of the constituents of Nigerian propolis. |
| first_indexed | 2024-04-11T06:13:57Z |
| format | Article |
| id | doaj.art-5230703d473c4eab8598a5c21f0b295e |
| institution | Directory Open Access Journal |
| issn | 2667-1425 |
| language | English |
| last_indexed | 2024-04-11T06:13:57Z |
| publishDate | 2022-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Pharmacological Research - Modern Chinese Medicine |
| spelling | doaj.art-5230703d473c4eab8598a5c21f0b295e2022-12-22T04:41:06ZengElsevierPharmacological Research - Modern Chinese Medicine2667-14252022-12-015100183Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitusEmmanuel I. Ugwor0Adewale S. James1Adekunle I. Amuzat2Emmanuel O. Ezenandu3Victory C. Ugbaja4Regina N. Ugbaja5Department of Biochemistry and Molecular Biology, Federal University of Viçosa, Viçosa, Minas Gerais, Brazil; Department of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria; Corresponding author at: Department of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Ogun State, Nigeria.Department of Chemical Sciences, Faculty of Science, Augustine University, Ilara-Epe, Lagos State, NigeriaDepartment of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Ogun State, NigeriaDepartment of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Ogun State, NigeriaDepartment of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Ogun State, NigeriaDepartment of Biochemistry, College of Biosciences, Federal University of Agriculture, Abeokuta, Ogun State, NigeriaPropolis is a common remedy in Chinese medicine. We have previously demonstrated the anti-diabetic potentials of Nigerian propolis. However, the underlying mechanisms against type-2 diabetes mellitus (T2DM) remain unclear. This study used network pharmacology-based analysis to unravel the possible mechanisms of NP's anti-T2DM activity. Previously identified compounds in NP were retrieved from literature, screened for drug-likeness, and used to retrieve targets associated with T2DM, from which compound-target, protein-protein interaction, and target-pathways networks were constructed. Network pharmacology-based and enrichment analyses were conducted on the networks. Further, NP's inhibitory activity against targets identified in network analyses was assessed in-vitro. Library search revealed 202 previously reported compounds in NP; 96 were retained after screening for drug-likeness. However, only 44 NP compounds interacted with T2DM-associated targets, with 2-ethyl-1,4-dimethoxybenzene as the most active component. Network analyses revealed 167 putative targets, with HSP90AA1, JUN, ESR1, STAT3, CYP3A4, PTGS2, RELA, VEGFA, CYP2C9, and PPARG as the core anti-T2DM targets of NP compounds. Gene ontology analyses indicated that these targets were predominantly localised in the plasma membrane and cytoplasm and primarily involved in regulatory, signal transduction and cellular response processes. KEGG pathway enrichment implicated metabolic pathways (involving lipids), AGE-RAGE, and calcium/cAMP, among others, in the anti-T2DM effects of the compounds. Furthermore, in vitro pharmacological assessment demonstrated appreciable inhibitory effects of 2-ethyl-1,4-dimethoxybenzene against α-amylase, α-glucosidase, and HMG-CoA reductase. This study provides holistic mechanistic insights into the anti-T2DM activities of the constituents of Nigerian propolis.http://www.sciencedirect.com/science/article/pii/S2667142522001439Nigerian propolisNetwork pharmacologyType-2 diabetesBioactive compounds |
| spellingShingle | Emmanuel I. Ugwor Adewale S. James Adekunle I. Amuzat Emmanuel O. Ezenandu Victory C. Ugbaja Regina N. Ugbaja Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitus Pharmacological Research - Modern Chinese Medicine Nigerian propolis Network pharmacology Type-2 diabetes Bioactive compounds |
| title | Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitus |
| title_full | Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitus |
| title_fullStr | Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitus |
| title_full_unstemmed | Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitus |
| title_short | Network pharmacology-based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type-2 diabetes mellitus |
| title_sort | network pharmacology based elucidation of bioactive compounds in propolis and putative underlying mechanisms against type 2 diabetes mellitus |
| topic | Nigerian propolis Network pharmacology Type-2 diabetes Bioactive compounds |
| url | http://www.sciencedirect.com/science/article/pii/S2667142522001439 |
| work_keys_str_mv | AT emmanueliugwor networkpharmacologybasedelucidationofbioactivecompoundsinpropolisandputativeunderlyingmechanismsagainsttype2diabetesmellitus AT adewalesjames networkpharmacologybasedelucidationofbioactivecompoundsinpropolisandputativeunderlyingmechanismsagainsttype2diabetesmellitus AT adekunleiamuzat networkpharmacologybasedelucidationofbioactivecompoundsinpropolisandputativeunderlyingmechanismsagainsttype2diabetesmellitus AT emmanueloezenandu networkpharmacologybasedelucidationofbioactivecompoundsinpropolisandputativeunderlyingmechanismsagainsttype2diabetesmellitus AT victorycugbaja networkpharmacologybasedelucidationofbioactivecompoundsinpropolisandputativeunderlyingmechanismsagainsttype2diabetesmellitus AT reginanugbaja networkpharmacologybasedelucidationofbioactivecompoundsinpropolisandputativeunderlyingmechanismsagainsttype2diabetesmellitus |